[{"address1": "16 Abba Hillel Road", "city": "Ramat Gan", "zip": "5250608", "country": "Israel", "phone": "972 3 693 8448", "website": "https://www.galmedpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Allen  Baharaff", "age": 59, "title": "Co-Founder, President, CEO & Chairman", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 972158, "exercisedValue": 0, "unexercisedValue": 1834}, {"maxAge": 1, "name": "Mr. Doron  Cohen", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 245982, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Guy  Nehemya", "age": 39, "title": "COO & Data Protection Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 287036, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yohai  Stenzler CPA", "age": 41, "title": "Chief Accounting Officer", "yearBorn": 1983, "fiscalYear": 2023, "totalPay": 290568, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Liat  Hayardeny MBA, Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 47934, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tali  Gorfine", "age": 54, "title": "Medical Consultant", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 202763, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.5, "open": 2.48, "dayLow": 2.45, "dayHigh": 2.685, "regularMarketPreviousClose": 2.5, "regularMarketOpen": 2.48, "regularMarketDayLow": 2.45, "regularMarketDayHigh": 2.685, "beta": 0.658, "trailingPE": 0.037578885, "forwardPE": -2.5436893, "volume": 19044, "regularMarketVolume": 19044, "averageVolume": 35445, "averageVolume10days": 21080, "averageDailyVolume10Day": 21080, "bid": 1.86, "ask": 3.16, "bidSize": 200, "askSize": 200, "marketCap": 4341313, "fiftyTwoWeekLow": 2.235, "fiftyTwoWeekHigh": 23.8, "fiftyDayAverage": 2.88872, "twoHundredDayAverage": 3.82686, "currency": "USD", "enterpriseValue": -13191670, "floatShares": 1320370, "sharesOutstanding": 1656990, "sharesShort": 6825, "sharesShortPriorMonth": 10147, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0041, "heldPercentInsiders": 0.01286, "heldPercentInstitutions": 0.03085, "shortRatio": 0.23, "shortPercentOfFloat": 0.0042, "impliedSharesOutstanding": 1656990, "bookValue": 12.234, "priceToBook": 0.21415725, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -6324000, "trailingEps": 69.72, "forwardEps": -1.03, "lastSplitFactor": "1:12", "lastSplitDate": 1724976000, "enterpriseToEbitda": 1.97, "52WeekChange": -0.44736844, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "GLMD", "underlyingSymbol": "GLMD", "shortName": "Galmed Pharmaceuticals Ltd.", "longName": "Galmed Pharmaceuticals Ltd.", "firstTradeDateEpochUtc": 1394717400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ade4d27e-0850-308a-ae7b-98b5c772bca9", "messageBoardId": "finmb_114779940", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.62, "recommendationKey": "none", "totalCash": 17140000, "totalCashPerShare": 11.374, "ebitda": -6696000, "quickRatio": 6.987, "currentRatio": 7.035, "returnOnAssets": -0.21979, "returnOnEquity": -0.37219003, "freeCashflow": -2778625, "operatingCashflow": -4809000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]